Past Keynote Speakers
2025 LOWVELO Symposium
Philip Greenberg, M.D.
Phil Greenberg is a Professor of Medicine & Immunology at the University of Washington and Head of the Program in Immunology at the Fred Hutchinson Cancer Center. His research has focused on elucidating fundamental principles of T cell and tumor interactions and developing cellular and molecular approaches to manipulate T cell immunity. He was elected to the National Academy of Sciences and is a previous President of the American Association for Cancer Research.
2024 LOWVELO Symposium
James Allison, Ph.D.
Dr. James Allison earned the 2018 Nobel Prize in Physiology or Medicine, which he shared with Dr. Tasuku Honjo, "for their discovery of cancer therapy by inhibition of negative immune regulation." He is the Chair of the Department of Immunology and Director of the Parker Institute for Cancer Research at M.D. Anderson Cancer Center.
Padmanee Sharma, M.D., Ph.D.
Dr. Padmanee Sharma is the T.C. and Jeanette Hsu Endowed Chair in Cell Biology and Co-Director of the Parker Institute for Cancer Immunotherapy at M.D. Anderson Cancer Center. She is a nationally and internationally renowned physician scientist who is a pioneer in the field of immune checkpoint therapy.
2023 LOWVELO Symposium
Luisel Ricks-Santi, Ph.D.
Dr. Luisel Ricks-Santi is a cancer genomics researcher and population scientist. She serves as associate director for diversity, equity and inclusion at the University of Florida Cancer Center.
Robert Winn, M.D.
Dr. Robert Winn is director and Lipman Chair in Oncology at VCU Massey Cancer Center and senior associate dean for cancer innovation and professor of pulmonary disease and critical care medicine, VCU School of Medicine.
2022 LOWVELO Symposium
William G. Kaelin, Jr., M.D.
Dr. William G. Kaelin, Jr., is an investigator at Dana-Farber Cancer Institute. In 2019, he was awarded the Nobel Prize in medicine or physiology along with Peter Ratcliffe and Gregg Semenza.
Edith P. Mitchell, M.D.
Dr. Edith P. Mitchell is program leader for gastrointestinal oncology at Sidney Kimmel Cancer Center and serves as the leader of the Jefferson Cancer Network's GI Cancer Working Group.
